PPARγ gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men

Metabolism: Clinical and Experimental

Volumn 52, Issue 2, 2003, Pages 209-212

  Kahara, Toshio ^a,b   Takamura, Toshinari ^a,b   Hayakawa, Tetsuo ^a,b   Nagai, Yukihiro ^a,b   Yamaguchi, Hiromi ^a,b   Katsuki, Tatsuo ^a,b   Katsuki, Ken Ichi ^a,b   Katsuki, Michjo ^a,b   Kobayashi, Ken Ichi ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b Hokuriku Inst Wellness Sports Sci   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHOLESTEROL; FRUCTOSAMINE; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; TRIACYLGLYCEROL; CELL RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; AGED; ALLELE; ARTICLE; BODY FAT; BODY MASS; CLINICAL EXAMINATION; CLINICAL TRIAL; DIET RESTRICTION; DNA ISOLATION; EXERCISE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HEART RATE; HORMONE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; JAPAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PHYSICAL ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; BLOOD; GENETICS; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; REFERENCE VALUE;

ADULT; AGED; BLOOD GLUCOSE; EXERCISE; FASTING; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; TRANSCRIPTION FACTORS;

EID: 0037313934     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50038     Document Type: Article

References (19)

1. Young JC: Exercise prescription for individuals with metabolic disorders: Practical considerations. Sports Med 19:43-54, 1995
2. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156, 1994
3. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, et al: Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422, 1997
4. Lehmann JM, Moore LB, Smith-Oliver TA, et al: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270:12953-12956, 1995
5. Deeb SS, Fajas L, Nemoto M, et al: A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287, 1998
6. Ek J, Andersen G, Urhammer SA, et al: Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia 44:1170-1176, 2001
7. Brozek J: Body composition: Models and estimation equations. Am J Phys Anthropol 24:239-246, 1966
8. Yen C-J, Beamer BA, Negri C, et al: Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun 241:270-274, 1997
9. Kallen CB, Lazar MA: Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93:5793-5796, 1996
10. Hofmann C, Lorenz K, Braithwaite SS, et al: Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
11. De Vos P, Lefebvre AM, Miller SG, et al: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98:1004-1009, 1996
12. Altshuler D, Hirschhorn JN, Klannemark M, et al: The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80, 2000
13. Hara K, Okada T, Tobe K, et al: The Pro12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216, 2000
14. Mori Y, Kim-Motoyama H, Katakura T, et al: Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem Biophys Res Commun 251:195-198, 1998
15. Ringel J, Engeli S, Distler A, et al: Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun 254:450-453, 1999
16. Mancini FP, Vaccaro O, Sabatino L, et al: Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes. Diabetes 48:1466-1468, 1999
17. Oh EY, Min KM, Chung JH, et al: Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801-1804, 2000
18. Poirier O, Nicaud V, Cambien F, et al: The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ2 gene is not associated with postprandial responses to glucose or fat tolerance tests in young healthy subjects: The European Atherosclerosis Research Study II. J Mol Med 78:346-351, 2000
19. Kubota N, Terauchi Y, Miki H, et al: PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 4:597-609, 1999